[25]
If no protective order is in place when Novopharm produces the material that has been ordered to be produced, Novopharm fears that Abbott might disclose that material to the public as part of the evidence filed with the Court. Any of Novopharm's competitors could then obtain such confidential information for their own purposes, thereby completely and permanently removing any confidentiality that information ever had, and giving Novopharm's competitors an unfair advantage.